Alivus Life Sciences Limited

ALIVUS

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 2026682

    Quarter₹ croreYoY
    Sept 2024507-14.9%
    Dec 2024642+12.1%
    Mar 2025650+21.0%
    Jun 2025602+2.2%
    Sept 2025588+16.0%
    Dec 2025673+4.8%
    Mar 2026689+6.1%
    Jun 2026640+6.4%
    Sept 2026682+16.0%
  • ₹ crore

    Sept 202620

    Quarter₹ crore
    Sept 20249
    Dec 202410
    Mar 202510
    Jun 20259
    Sept 202515
    Dec 202514
    Mar 202623
    Jun 202622
    Sept 202620
  • ₹ crore

    Sept 2026702

    Quarter₹ crore
    Sept 2024515
    Dec 2024652
    Mar 2025660
    Jun 2025611
    Sept 2025603
    Dec 2025687
    Mar 2026712
    Jun 2026663
    Sept 2026702
  • Cost structure
  • ₹ crore

    Sept 202670

    Quarter₹ crore
    Sept 202462
    Dec 202466
    Mar 202567
    Jun 202562
    Sept 202566
    Dec 202566
    Mar 202678
    Jun 202668
    Sept 202670
  • ₹ crore

    Sept 2026440

    Quarter₹ crore
    Sept 2024388
    Dec 2024467
    Mar 2025468
    Jun 2025448
    Sept 2025429
    Dec 2025463
    Mar 2026496
    Jun 2026451
    Sept 2026440
  • Exceptional items and tax
  • ₹ crore

    Sept 2026262

    Quarter₹ crore
    Sept 2024127
    Dec 2024185
    Mar 2025191
    Jun 2025163
    Sept 2025174
    Dec 2025198
    Mar 2026216
    Jun 2026212
    Sept 2026262
  • ₹ crore

    Sept 202665

    Quarter₹ crore
    Sept 202432
    Dec 202448
    Mar 202549
    Jun 202541
    Sept 202544
    Dec 202548
    Mar 202653
    Jun 202652
    Sept 202665
  • Profit
  • ₹ crore

    Sept 2026197

    Quarter₹ croreYoY
    Sept 202495-19.7%
    Dec 2024137+15.3%
    Mar 2025142+44.9%
    Jun 2025122+9.0%
    Sept 2025130+36.4%
    Dec 2025150+9.7%
    Mar 2026163+14.7%
    Jun 2026160+31.7%
    Sept 2026197+51.3%
  • Per share
  • ₹ per share

    Sept 202616.02

    Quarter₹ per share
    Sept 20247.78
    Dec 202411.18
    Mar 202511.57
    Jun 20259.91
    Sept 202510.60
    Dec 202512.25
    Mar 202613.23
    Jun 202613.04
    Sept 202616.02
  • Leverage
  • Debt to equity

    times

    Sept 20240.00x

    Quartertimes
    Sept 20240.00x
    Dec 2024—
    Mar 2025—
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
    Sept 2026—
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
507642650602588673689640682
Revenue YoY-14.9%+12.1%+21.0%+2.2%+16.0%+4.8%+6.1%+6.4%+16.0%
9101091514232220
515652660611603687712663702
Cost structure
626667626666786870
388467468448429463496451440
Exceptional items and tax
127185191163174198216212262
324849414448535265
Profit
95137142122130150163160197
Net profit YoY-19.7%+15.3%+44.9%+9.0%+36.4%+9.7%+14.7%+31.7%+51.3%
Per share
7.7811.1811.579.9110.6012.2513.2313.0416.02
Leverage
Debt to equity0.00x————————

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.